"10.1371_journal.pone.0055681","plos one","2013-02-08T00:00:00Z","Francisco Javier Gracia-Aznarez; Victoria Fernandez; Guillermo Pita; Paolo Peterlongo; Orlando Dominguez; Miguel de la Hoya; Mercedes Duran; Ana Osorio; Leticia Moreno; Anna Gonzalez-Neira; Juan Manuel Rosa-Rosa; Olga Sinilnikova; Sylvie Mazoyer; John Hopper; Conchi Lazaro; Melissa Southey; Fabrice Odefrey; Siranoush Manoukian; Irene Catucci; Trinidad Caldes; Henry T Lynch; Florentine S M Hilbers; Christi J van Asperen; Hans F A Vasen; David Goldgar; Paolo Radice; Peter Devilee; Javier Benitez","Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Human Genotyping Unit –CEGEN, Spanish National Cancer Centre (CNIO), Madrid, Spain; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Genomics Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain; Laboratorio de Oncología Molecular, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain; Instituto de Biología y Genética Molecular (IBGM-UVA.CSIC), Valladolid, Spain; Bioinformatics Unit, Sistemas Genómicos, Valencia, Spain; CNRS UMR5286 INSERM U1052, Université Lyon 1, Cancer Research Center of Lyon, Center Léon Bérard, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France; Centre for Molecular, Environmental, Genetic and Analytical Epidemiology, School of Population Health, The University of Melbourne, Victoria, Australia; Molecular Diagnostic Unit, Hereditary Cancer Program, Institut Català d’Oncologia-IDIBELL, Barcelona, Spain; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Victoria, Australia; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, Nebraska, United States of America; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; Foundation for the Detection of Hereditary Tumors, Leiden, The Netherlands; Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain","Conceived and designed the experiments: FJGA AGN JB. Performed the experiments: FJGA VF PP OD LM MS IC FSMH. Analyzed the data: FJGA VF GP LM AGN JMRR JB. Contributed reagents/materials/analysis tools: FJGA GP PP MH MD AO AGN OS S. Mazoyer JH CL MS FO S. Manoukian IC TC HTL FSMH CJVA HFAV DG PR PD. Wrote the paper: FJGA JB.","JMRR works in the company Sistemas Genomicos, but this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Francisco Javier Gracia-Aznarez","FJGA",28,TRUE,3,8,7,2,TRUE,TRUE,TRUE,10,"14;15;17;20;21;23;24;25;26;27",TRUE
